Articles in the News Category
News »
M2 announced today higher than expected 2011 forecast.
According to the guidance M2 expects substantial growth since the last financial year.
Revenue is forecast to grow by 12 per cent in 2010-11 to between $425 million and $445 million from the forecast $380 million to $400 million in 2009-10.
Net profit is expected to explode 52 per cent to $22 million and $23.5 million in financial 2011 from the 2009-10 guidance figure of about $15 million.
Earnings per share is forecast to rise 36 per cent to between 18.1 cents and 19.4 cents from …
News »
Headline Group popped 18% yesterday, up 5 cents to 33c on huge volume of 1.4M shares after this big announcement.
The highlights of the announcement were:
Mothercare PLC proposed acquisition of 25% of Headline Group via investment of $12.2M.
“Baby on a Budget” acquisition in W.A. Seven stores, deal multiple of 4x EBITDA .
Headline to acquire 100% ownership of Skansen KCG in returns for shares in HLD.
Current stores operating above expectations.
Roll-out of Mothercare stores to be accelerated.
Headline Group Limited has exclusive rights and is currently launching the world’s leading retail parenting centre into Australia under the international brands of Mothercare and …
Commentary, News »
Jeremy Cooper, the superannuation reviewer not the brewer, has released A Conversation About SMSFs. This document is as refreshing Cooper’s Pale Ale, Cooper even leads off with a Coopers joke.
I encourage all SMSF trustees to read the document, though in summary Cooper says SMSFs are doing well and despite concentrated asset allocations* are performing as good as if not better than other investment vehicles.
SMSFs might be able to aspire to this [excellent performance] because:
SMSFs can pursue asset allocations that would be difficult to implement in an APRA-regulated fund;
SMSFs can have longer-term investment …
News »
The Super System Review is examining Australia’s superannuation system in three phases. Today the Cooper Review will release the phase three issue paper. Here’s the timeline for the review.
There’s been some great if obvious findings so far.
MORE than $13 million a day is being sucked from Australian retirement savings because of underperforming retail superannuation funds and commissions paid to financial planners…via Business Age
News »
2x leverage wasn’t enough so we got 3x, now Kelly Capital are taking it to an extreme with 100x leverage. It’s good to see someone at the SEC has a sense of humour, Ben Meriwether is a funny guy. Of course the powers that be at Kelly Capital also appear to be full of mirth calling their leveraged ETFs, SINK and SOAR.
“These are intended for attentive traders only,” says Kelly Capital chief executive officer Jason Kelly. “The extreme leverage employed will cause both funds to go bankrupt within the course of most trading …
News »
11 Administrators’ Opinion
the option of the administration ending is clearly not viable for the GS Group.
At this stage, as no DOCA proposal has been put forward for consideration, and no such proposal is pending to the best of our knowledge, this option falls away and cannot be considered.
The only remaining option available to creditors is to wind up each of the GS Group Companies.
Based on the above, it is therefore our opinion and recommendation that creditors should resolve that each of the GS Group Companies is wound up.
See Final Report for Great …
News »
MMC Contrarian (MMA.AX) holders voted with their shares. Holders of 33% of MMA rejected GPG’s scandalously low bids of $0.48 and then $0.50. I haven’t heard what Nicholas Bolton has done with his 5.5% holding. Bolton’s Australian Style Group started buying MMA in May and bought consistently through until September 10.
News »
GPG at 65% of MMA and a new consitution
Guinness Peat Group (GPG) announced 64.15% yesterday and with another 1.8million bought so far today they should end the day owning close to 66% of MMA.
75% allows GPG to change constitution. There was a new constitution out yesterday, which contained the amendments from AGM resolution 7.
I wonder what Nick Bolton is up to. Come on Nick leave me a comment.
The independent directions continue to say no. I’m wavering, but if everyone stands strong I will too!
Analysis, News »
Relenza sales were £182 million reflecting continued orders from Governments for pandemic stockpiling. That’s around $24M in royalties for Biota. Production increases on target for 190m by end of 2009.
£45M in US
£38 in Europe
£99 RoW via GSK announcement
Royalties owing to Biota Holdings (BTA) from GSK’s Relenza sales of $23M, narrowly beating consensus estimates.
Production increases on target for 190m by end of 2009. Waiting confirmation from conference call.









